Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTIS2023-510561-10-00
CTIS2023-510561-10-00Active, not recruitingPhase 1

Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – A Pilot Randomized Controlled Trial - The ACCURATE Study

GCP-Service International West GmbH0 sites60 target enrollmentStarted: March 27, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
60
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 65+ (—)
Sex
All

Inclusion Criteria

  • •Written informed consent prior to study participation, Adult patients (= 18 years), Patients undergoing open-heart surgery with the use of cardiopulmonary bypass (CPB), who are defined as high risk based on having (i) combined valve or CABG or multiple valve surgeries, or combined cardiac/aortic surgical procedures and (ii) at least one of the following additional risk factors: a. a high perioperative risk profile, defined as a predicted operative mortality of = 8% (EuroSCORE II) b. Age >70 years c. Clinical Frailty Scale >4 d. Urgent need for cardiac surgery (defined as to be performed within 24 to 48 hours after admission to hospital). e. Left ventricular ejection fraction <35%, The investigator considers the patient to be suitable for participating in the study

Exclusion Criteria

  • •Patients with history of recurrent formation of kidney stones (oxalate urolithiasis) or recent history (within 1 year) of any kidney stones, Patients who are enrolled in industry sponsored interventional trials. The enrolment of patients included in interventional investigator-initiated trials will be discussed on a case-by-case depending on potential confounders regarding this trial, Patients with severe renal insufficiency (CKD KDIGO Stage 4/5 or glomerular filtration rate < 30 ml/min), Patients with known glucose-6-phosphate dehydrogenase deficiency., Patients with known thalassemia, hemochromatosis and sideroblastic anemia., Patients with known hypersensitivity to the Investigational Medicinal Product (IMP) or against any of its ingredients, Patients who are pregnant or lactating, Patients who are receiving high-dose IV vitamin C (enteral or oral vitamin C is allowed) already before surgery (>100 mg/kg/day as daily dose for > 1 week, Patients who are moribund (not expected to survive the next 72 hours from screening evaluation), Patients with severe acid-base or electrolyte imbalances

Investigators

Similar Trials

Not yet recruiting
Phase 2
Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – A Pilot Randomized Controlled Trial
DRKS00033611niklinik Würzburg60
Not yet recruiting
Phase 4
Effect of vitamin C in assesssing the death rate in patients with multiple trauma
CTRI/2019/07/020370Jawaharlal Institute of Postgraduate Medical Education and Research
Completed
Phase 3
Effect of Vitamin C on Stress in Peritoneal Dialysis PatientsPeritoneal dialysis patients.End-stage renal disease
IRCT2016050227675N2Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences40
Recruiting
Phase 2
The effect of vitamin C supplementation on oxidative stress indices and skin repigmentation of patient with vitiligoVitiligo.L80- Diseases of the skin and subcutaneous tissue.
IRCT20230123057193N1Research assistant of Tehran University of Medical Sciences44
Recruiting
Phase 3
Impact of Vitamin C Supplementation on delirium
IRCT20080830001127N7Tabriz University of Medical Sciences180